Search research articles
Contact Us
Filters
Showing results (201-210 of 504) with videos related to
Page
of 51
Sort By:
Blood
|
August 20, 2016
Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML
Mohammed Dany, Salih Gencer, Rose Nganga, et al.
Cancer Research
|
February 20, 2007
The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore
Paul S Brookes, Kimberly Morse, Denise Ray, et al.
Scientific Reports
|
June 10, 2021
DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia
Eric Haines, Yuki Nishida, Michael I Carr, et al.
Haematologica
|
December 23, 2020
Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and resensitizes acute myeloid leukemia to BCL-2 inhibition
Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
British Journal of Haematology
|
June 20, 2014
SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia
Olga Frolova, Juliana Benito, Chris Brooks, et al.
Blood
|
April 12, 2012
Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment
Ye Chen, Rodrigo Jacamo, Yue-xi Shi, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 20, 2013
PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment
Linhua Jin, Yoko Tabe, Kensuke Kojima, et al.
Journal for Immunotherapy of Cancer
|
March 16, 2021
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2<sup>+</sup> breast cancer stem-like cells
Stanley Ly, Vivek Anand, Fouad El-Dana, et al.
British Journal of Haematology
|
April 13, 2011
High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei
Dinesh Rakheja, Sergej Konoplev, Mu Su, et al.
Cancer
|
March 26, 2004
Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein
Barbara Scappini, Simona Gatto, Francesco Onida, et al.
Page
of 51
Search research articles
Search
Showing results (201-210 of 504) with videos related to
Sort By:
Page
of 51
Blood
|
August 20, 2016
Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML
Mohammed Dany, Salih Gencer, Rose Nganga, et al.
Cancer Research
|
February 20, 2007
The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore
Paul S Brookes, Kimberly Morse, Denise Ray, et al.
Scientific Reports
|
June 10, 2021
DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia
Eric Haines, Yuki Nishida, Michael I Carr, et al.
Haematologica
|
December 23, 2020
Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and resensitizes acute myeloid leukemia to BCL-2 inhibition
Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
British Journal of Haematology
|
June 20, 2014
SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia
Olga Frolova, Juliana Benito, Chris Brooks, et al.
Blood
|
April 12, 2012
Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment
Ye Chen, Rodrigo Jacamo, Yue-xi Shi, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 20, 2013
PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment
Linhua Jin, Yoko Tabe, Kensuke Kojima, et al.
Journal for Immunotherapy of Cancer
|
March 16, 2021
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2<sup>+</sup> breast cancer stem-like cells
Stanley Ly, Vivek Anand, Fouad El-Dana, et al.
British Journal of Haematology
|
April 13, 2011
High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei
Dinesh Rakheja, Sergej Konoplev, Mu Su, et al.
Cancer
|
March 26, 2004
Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein
Barbara Scappini, Simona Gatto, Francesco Onida, et al.
Page
of 51